Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Sort ascending Activity Code(s) Title
PAR-24-131 April 6, 2027 R43/R44 Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)
PAR-24-132 April 6, 2027 R43/R44 Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
PAR-24-133 April 6, 2027 R41/R42 Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)
PAR-24-134 April 6, 2027 R41/R42 Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
RFA-MH-24-280 February 9, 2027 R01 BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
RFA-NS-24-031 January 29, 2027 R18 BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
RFA-NS-24-016 January 29, 2027 UG3/UH3 BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
RFA-NS-24-017 January 29, 2027 UH3 BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
RFA-NS-25-012 January 16, 2027 R61/R33 HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
PAR-24-144 January 8, 2027 R16 Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
PAR-24-059 January 8, 2027 R01 Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
PAR-24-145 January 8, 2027 R16 Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
NOT-HL-23-117 January 8, 2027 R01 Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers
RFA-NS-24-019 January 8, 2027 UG3/UH3 HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
PAR-23-299 January 8, 2027 R21 Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
PAR-23-298 January 8, 2027 R01 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
PAR-23-285 January 8, 2027 R34 Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
NOT-OD-24-058 January 8, 2027 U24,R01,R21,R34,UG3/UH3,R03 Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
PA-24-141 January 8, 2027 R13 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
PAR-24-077 January 8, 2027 R01 Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
top of pageBACK TO TOP